Drug Filter >
  • Targets: Bcr-Abl
  •   > 
Drug Filter
Status:
Approved (5) Phase Ⅲ (1) Phase Ⅱ (6) Phase Ⅰ (4)
Clinical Stage:
Pending (3) Active (6) Discontinued (2)
Company:
Novartis (3) Beijing Meidisai Medical Technology (1) Bristol-Myers Squibb (1) China Shijiazhuang Pharmaceutical Group/CSPC (1) CytRx (1) Deciphera (1) Exelixis (1) Gloria Pharmaceuticals (1) Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences (1) Hansoh Pharma (1) IL-Yang (1) Natco (1) Otsuka (1) Pfizer (1) Piramal Phytocare (1) Sichuan University (1) 未知 (0)
Indication:
Acute lymphoblastic leukaemia (ALL) (3) Acute myeloid Leukemia (AML) (1) Chronic lymphocytic leukemia (CLL) (2) Chronic myeloid leukemia (CML ) (11) Gastrointestinal stromal tumors (GISTs) (2) Multiple myeloma (MM) (1) Myelodysplastic syndrome (MDS) (1) Myeloid leukemia (1) Solid tumours (2) Myeloproliferative Disorders (MPD) (1) Hypereosinophilic syndrome (HES) (1) Dermatofibrosarcoma protuberans (DFSP) (1) Chronic eosinophilic leukemia (CEL) (1)
Country:
US (3) KR (1) CH (1)
Aprv. Year:
2012 (2) 2007 (1) 2006 (1) 2001 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 Next Last GO
Recently Viewed Drugs:

CopyRight©2017药渡经纬信息科技(北京)有限公司 电子与信息服务业务经营许可证151001号

京ICP备14047345| 京公安网备11010802017043号 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)

药渡APP Drug A-Z
药渡APP
药渡微信二维码
微信二维码